(Q54653647)

English

Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide

scientific article published on September 1, 1972

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazolyl)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide (English)

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

E. H. Wiseman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4630489

15 February 2023

J. Chiaini

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4630489

15 February 2023

language of work or name

0 references

publication date

1 September 1972

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

full work available at URL

https://api.elsevier.com/content/article/PII:0006295272903838?httpAccept=text/xml

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

https://api.elsevier.com/content/article/PII:0006295272903838?httpAccept=text/plain

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Biochemical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

21

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

17

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

2323-2334

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

Antinflammatory 2-aryl-1,3-indandiones

1

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Preparation and antiinflammatory activity of some 2-arylbenzo[b] thiophen-3(2H)-one 1,1-dioxides

2

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Dioxoisoquinoline-4-carboxanilides—A New Class of Non-steroidal Anti-inflammatory Agents

3

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Antiinflammatory 3,4-dihydro-2-alkyl-3-oxo-2H-1,2-benzothiazine-4-carboxamide 1,1-dioxides

5

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Synthesis and antiinflammatory activity of some 3-carboxamides of 2-alkyl-4-hydroxy-2H-1,2-benzothiazine 1,1-dioxide

6

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Excretion and metabolism of a nonsteroidal antiinflammatory agent, 4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxanilide 1,1-dioxide, in rat, dog, monkey, and man

7

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Treatment of adjuvant arthritis in rats with anti-inflammatory drugs

12

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Plasma inflammation units: An objective method for investigating effects of drugs on experimental inflammation

13

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Kinetics of plasma drug levels after sustained release dosage

17

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

THE DISTRIBUTION, EXCRETION AND METABOLISM OF BENZQUINAMIDE

18

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Indomethacin: a survey of clinical trials

21

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Benefits and toxicity of phenylbutazone (butazolidin) in rheumatoid arthritis

23

1 reference

10.1016/0006-2952(72)90383-8

https://api.crossref.org/works/10.1016/0006-2952(72)90383-8

15 February 2023

Identifiers

10.1016/0006-2952(72)90383-8

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/4630489

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54653647&oldid=2144489890"